US20040231909A1 - Motorized vehicle having forward and backward differential structure - Google Patents

Motorized vehicle having forward and backward differential structure Download PDF

Info

Publication number
US20040231909A1
US20040231909A1 US10/440,861 US44086103A US2004231909A1 US 20040231909 A1 US20040231909 A1 US 20040231909A1 US 44086103 A US44086103 A US 44086103A US 2004231909 A1 US2004231909 A1 US 2004231909A1
Authority
US
United States
Prior art keywords
motorized vehicle
propeller shaft
thrust bearings
direction thrust
bearing seat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/440,861
Other languages
English (en)
Inventor
Tai-Yang Luh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TAIWAN POWER INDUSTRIAL Co Ltd
Original Assignee
TAIWAN POWER INDUSTRIAL Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32771871&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20040231909(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by TAIWAN POWER INDUSTRIAL Co Ltd filed Critical TAIWAN POWER INDUSTRIAL Co Ltd
Assigned to TAIWAN POWER INDUSTRIAL CO., LTD. reassignment TAIWAN POWER INDUSTRIAL CO., LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LUH, TAI-YANG
Publication of US20040231909A1 publication Critical patent/US20040231909A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Definitions

  • the present invention relates to a motorized vehicle, and more particularly to a motorized vehicle having a forward and backward differential structure.
  • a conventional motorized vehicle comprises a differential mounted on the transmission gear of the gear box.
  • the differential consists of a bevel gear set.
  • the power of the motor is reduced by the reduction mechanism.
  • the reduced power is transmitted by the transmission gear of the gear box and the bevel gear of the differential to the propeller shafts at the left and right sides, to drive and rotate the wheels at the left and right sides.
  • the motorized vehicle is turned, the turning diameter of the wheel at the inner side is shorter than that of the wheel at the outer side, so that the differential consisting of the bevel gear set is used to balance the difference of the rotation speed between the wheel at the inner side and the wheel at the outer side.
  • the primary objective of the present invention is to provide a motorized vehicle having a forward and backward differential structure.
  • Another objective of the present invention is to provide a motorized vehicle, wherein when the two rear wheels are subjected to a drag or resistance and cannot be rotated with the propeller shaft synchronously, the single-direction thrust bearing will idle, thereby producing a differential effect.
  • a further objective of the present invention is to provide a motorized vehicle, wherein the single-direction thrust bearings located at one of the two rear wheels is used to drive the motorized vehicle to move forward, and the single-direction thrust bearings located between the other rear wheel is used to drive the motorized vehicle to move backward.
  • a further objective of the present invention is to provide a motorized vehicle having a differential structure which can replace the conventional differential consisting of a bevel gear set, thereby reducing costs of fabrication, and thereby simplifying the construction.
  • a motorized vehicle comprising:
  • a propeller shaft mounted on the two rear wheels and having two ends;
  • the single-direction thrust bearings located between one of the two rear wheels and a first end of the propeller shaft has a rotation direction opposite to a normal rotation direction of the propeller shaft to drive the motorized vehicle to move forward;
  • the single-direction thrust bearings located between the other one of the two rear wheels and a second end of the propeller shaft has a rotation direction opposite to a reverse rotation direction of the propeller shaft to drive the motorized vehicle to move backward.
  • FIG. 1 is a partially exploded perspective view of a motorized vehicle in accordance with the preferred embodiment of the present invention
  • FIG. 2 is a front plan cross-sectional assembly view of the motorized vehicle as shown in FIG. 1;
  • FIG. 3 is a top plan cross-sectional assembly view of the motorized vehicle as shown in FIG. 1;
  • FIG. 4 is a perspective assembly view of the differential structure of the motorized vehicle in accordance with the preferred embodiment of the present invention.
  • FIG. 5 is an exploded perspective view of the differential structure of the motorized vehicle in accordance with the preferred embodiment of the present invention.
  • FIG. 6 is a side plan cross-sectional view of the differential structure of the motorized vehicle as shown in FIG. 4;
  • FIG. 7 is a schematic top plan operational view showing the turning state of the motorized vehicle in accordance with the preferred embodiment of the present invention.
  • FIG. 8 is a side plan cross-sectional assembly view showing the normal transmission state of the motorized vehicle in accordance with the preferred embodiment of the present invention.
  • FIG. 9 is a side plan cross-sectional assembly view showing the differential state of the motorized vehicle in accordance with the preferred embodiment of the present invention.
  • a motorized vehicle 10 having a forward and backward differential structure in accordance with the preferred embodiment of the present invention has a rear portion provided with a propeller shaft 11 having two ends each provided with a catch flange 12 , a keyway 13 (see FIG. 6), and an outer thread 14 (see FIG. 6).
  • Each of the two ends of the propeller shaft 11 is provided with a bearing cap 20 , two single-direction thrust bearings 30 , a bearing seat 40 , and a fixing member 50 .
  • the bearing seat 40 is formed with a plurality of screw bores 41 .
  • the bearing cap 20 is formed with a plurality of through holes 21 .
  • the motorized vehicle 10 further comprises a plurality of locking screws 22 each extended through a respective one of the through holes 21 and each screwed into a respective one of the screw bores 41 , thereby fixing the bearing cap 20 on the bearing seat 40 .
  • Each of the two single-direction thrust bearings 30 is mounted between the bearing seat 40 and the propeller shaft 11 .
  • Each of the two single-direction thrust bearings 30 has an inner race formed with an inner keyway 31 .
  • the motorized vehicle 10 further comprises a first key 32 secured in the inner keyway 31 of each of the two single-direction thrust bearings 30 and the keyway 13 of the propeller shaft 11 , so that each of the two single-direction thrust bearings 30 is combined with the propeller shaft 11 .
  • Each of the two single-direction thrust bearings 30 has an outer race formed with an outer keyway 310 .
  • the bearing seat 40 has two sides each formed with a keyway 42 .
  • the motorized vehicle 10 further comprises two second keys 320 each secured in the outer keyway 310 of a respective one of the two single-direction thrust bearings 30 and the keyway 42 of the bearing seat 40 , so that each of the two single-direction thrust bearings 30 is combined with the bearing seat 40 .
  • One of the two single-direction thrust bearings 30 is rested on and limited by the catch flange 12 of the propeller shaft 11 and the bearing cap 20 .
  • the fixing member 50 is secured on the propeller shaft 11 and is rested on the other one of the two single-direction thrust bearings 30 .
  • the fixing member 50 is formed with an inner thread 51 screwed on the outer thread 14 of the propeller shaft 11 , so that the fixing member 50 is fixed on the propeller shaft 11 .
  • the bearing seat 40 has a periphery provided with a fixing board 43 , and the motorized vehicle 10 further comprises two rear wheels 60 each secured on the fixing board 43 of the respective bearing seat 40 .
  • the fixing board 43 of the bearing seat 40 is formed with a plurality of through holes 44 .
  • Each of the two rear wheels 60 is formed with a plurality of through holes 62 .
  • the motorized vehicle 10 further comprises a plurality of locking bolts 45 each extended through a respective one of the through holes 44 of the fixing board 43 of the bearing seat 40 and a respective one of the through holes 62 of the respective rear wheel 60 , so that each of the two rear wheels 60 is fixed on the fixing board 43 of the respective bearing seat 40 .
  • the two single-direction thrust bearings 30 located at a first end of the propeller shaft 11 has a rotation direction opposite to the normal rotation direction (when the motorized vehicle 10 is moved forward) of the propeller shaft 11 to drive the motorized vehicle 10 to move forward
  • the two single-direction thrust bearings 30 located at a second end of the propeller shaft 11 has a rotation direction opposite to the reverse rotation direction (when the motorized vehicle 10 is moved backward) of the propeller shaft 11 to drive the motorized vehicle 10 to move backward.
  • the single-direction thrust bearings located at one of the two rear wheels is used to drive the motorized vehicle to move forward, and the single-direction thrust bearings located between the other rear wheel is used to drive the motorized vehicle to move backward.
  • the single-direction thrust bearing will idle, thereby producing a differential effect.
  • the motorized vehicle is driven by the two rear wheels.
  • the single-direction thrust bearings located at the left rear wheel is used to drive the motorized vehicle to move forward.
  • the single-direction thrust bearings located at the right rear wheel idles.
  • the single-direction thrust bearings located at the right rear wheel is used to drive the motorized vehicle to move backward.
  • the single-direction thrust bearings located at the left rear wheel idles.
  • the single-direction thrust bearings mounted on the two rear wheels form a differential effect when the motorized vehicle is turned or driven on an abnormal road condition.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Motor Power Transmission Devices (AREA)
US10/440,861 2003-01-15 2003-05-19 Motorized vehicle having forward and backward differential structure Abandoned US20040231909A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44086103P 2003-01-15 2003-01-15

Publications (1)

Publication Number Publication Date
US20040231909A1 true US20040231909A1 (en) 2004-11-25

Family

ID=32771871

Family Applications (7)

Application Number Title Priority Date Filing Date
US10/440,861 Abandoned US20040231909A1 (en) 2003-01-15 2003-05-19 Motorized vehicle having forward and backward differential structure
US10/758,307 Expired - Lifetime US7569345B2 (en) 2003-01-15 2004-01-14 Gene expression markers for breast cancer prognosis
US12/478,632 Expired - Lifetime US8034565B2 (en) 2003-01-15 2009-06-04 Gene expression markers for breast cancer prognosis
US13/221,549 Expired - Lifetime US8206919B2 (en) 2003-01-15 2011-08-30 Gene expression markers for breast cancer prognosis
US13/473,526 Expired - Lifetime US8741605B2 (en) 2003-01-15 2012-05-16 Gene expression markers for breast cancer prognosis
US14/257,723 Active 2026-07-13 US9944990B2 (en) 2003-01-15 2014-04-21 Gene expression markers for breast cancer prognosis
US15/897,617 Expired - Fee Related US11220715B2 (en) 2003-01-15 2018-02-15 Gene expression markers for breast cancer prognosis

Family Applications After (6)

Application Number Title Priority Date Filing Date
US10/758,307 Expired - Lifetime US7569345B2 (en) 2003-01-15 2004-01-14 Gene expression markers for breast cancer prognosis
US12/478,632 Expired - Lifetime US8034565B2 (en) 2003-01-15 2009-06-04 Gene expression markers for breast cancer prognosis
US13/221,549 Expired - Lifetime US8206919B2 (en) 2003-01-15 2011-08-30 Gene expression markers for breast cancer prognosis
US13/473,526 Expired - Lifetime US8741605B2 (en) 2003-01-15 2012-05-16 Gene expression markers for breast cancer prognosis
US14/257,723 Active 2026-07-13 US9944990B2 (en) 2003-01-15 2014-04-21 Gene expression markers for breast cancer prognosis
US15/897,617 Expired - Fee Related US11220715B2 (en) 2003-01-15 2018-02-15 Gene expression markers for breast cancer prognosis

Country Status (10)

Country Link
US (7) US20040231909A1 (https=)
EP (4) EP1587957B1 (https=)
JP (1) JP4723472B2 (https=)
AT (1) ATE470723T1 (https=)
AU (2) AU2004205878B2 (https=)
CA (5) CA3013889A1 (https=)
DE (1) DE602004027600D1 (https=)
DK (3) DK2230319T3 (https=)
ES (3) ES2725892T3 (https=)
WO (1) WO2004065583A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103465779A (zh) * 2013-09-17 2013-12-25 哈尔滨工程大学 双引擎全向四驱行进机构

Families Citing this family (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6984522B2 (en) 2000-08-03 2006-01-10 Regents Of The University Of Michigan Isolation and use of solid tumor stem cells
US8044259B2 (en) * 2000-08-03 2011-10-25 The Regents Of The University Of Michigan Determining the capability of a test compound to affect solid tumor stem cells
US20060062786A1 (en) * 2000-11-08 2006-03-23 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to TRAIL receptors
US7348003B2 (en) 2001-05-25 2008-03-25 Human Genome Sciences, Inc. Methods of treating cancer using antibodies that immunospecifically bind to TRAIL receptors
US20050214209A1 (en) * 2001-05-25 2005-09-29 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to TRAIL receptors
US20050129616A1 (en) * 2001-05-25 2005-06-16 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to TRAIL receptors
US7361341B2 (en) * 2001-05-25 2008-04-22 Human Genome Sciences, Inc. Methods of treating cancer using antibodies that immunospecifically bind to trail receptors
US20090226429A1 (en) * 2001-05-25 2009-09-10 Human Genome Sciences, Inc. Antibodies That Immunospecifically Bind to TRAIL Receptors
AU2002361784A1 (en) * 2001-12-20 2003-07-09 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to trail receptors
ES2374311T3 (es) * 2002-03-13 2012-02-15 Genomic Health, Inc. Obtención de perfil de expresión génica en tejidos tumorales biopsiados.
US20040231909A1 (en) * 2003-01-15 2004-11-25 Tai-Yang Luh Motorized vehicle having forward and backward differential structure
HUE050365T2 (hu) * 2003-06-24 2022-09-28 Genomic Health Inc Rákkiújulás valószínûségének elõrejelzése
AU2004258085B2 (en) 2003-07-10 2010-05-27 Genomic Health, Inc. Expression profile algorithm and test for cancer prognosis
US20050112622A1 (en) * 2003-08-11 2005-05-26 Ring Brian Z. Reagents and methods for use in cancer diagnosis, classification and therapy
US20060003391A1 (en) * 2003-08-11 2006-01-05 Ring Brian Z Reagents and methods for use in cancer diagnosis, classification and therapy
ES2636470T3 (es) 2004-04-09 2017-10-05 Genomic Health, Inc. Marcadores de expresión génica para predecir la respuesta a la quimioterapia
US20080131916A1 (en) * 2004-08-10 2008-06-05 Ring Brian Z Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy
US20100035240A1 (en) * 2004-08-10 2010-02-11 Cardiff Biologicals Limited Methods and kit for the prognosis of breast cancer
CA2580795A1 (en) * 2004-09-22 2006-04-06 Tripath Imaging, Inc. Methods and compositions for evaluating breast cancer prognosis
US8065093B2 (en) 2004-10-06 2011-11-22 Agency For Science, Technology, And Research Methods, systems, and compositions for classification, prognosis, and diagnosis of cancers
JP4939425B2 (ja) * 2004-11-05 2012-05-23 ジェノミック ヘルス， インコーポレイテッド 乳癌の治療反応の予後および予測の分子指標
CA2585571C (en) * 2004-11-05 2020-01-21 Genomic Health, Inc. Predicting response to chemotherapy using gene expression markers
WO2006063042A2 (en) * 2004-12-07 2006-06-15 Genentech, Inc. Selecting patients for therapy with a her inhibitor
CN102580084B (zh) 2005-01-21 2016-11-23 健泰科生物技术公司 Her抗体的固定剂量给药
EP1850874B1 (en) * 2005-02-23 2013-10-16 Genentech, Inc. Extending time to disease progression or survival in ovarian cancer patients using pertuzumab
JP2006316040A (ja) 2005-05-13 2006-11-24 Genentech Inc Ｈｅｒｃｅｐｔｉｎ（登録商標）補助療法
US20080275652A1 (en) * 2005-05-13 2008-11-06 Universite Libre De Bruxelles Gene-based algorithmic cancer prognosis
US20070099209A1 (en) * 2005-06-13 2007-05-03 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
JP2009505658A (ja) * 2005-08-24 2009-02-12 ブリストル−マイヤーズ スクイブ カンパニー 上皮増殖因子受容体モデュレーターに対する感受性を決定するためのバイオマーカーおよび方法
CA2628255C (en) 2005-10-31 2016-04-19 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
EP1946118A4 (en) 2005-11-10 2009-01-21 Aurelium Biopharma Inc TISSUE DIAGNOSIS OF BREAST CANCER
TW200731980A (en) * 2005-12-29 2007-09-01 Alcon Mfg Ltd RNAi-mediated inhibition of HIF1A for treatment of ocular angiogenesis
US7888019B2 (en) 2006-03-31 2011-02-15 Genomic Health, Inc. Genes involved estrogen metabolism
WO2007140958A2 (en) * 2006-06-02 2007-12-13 Glaxosmithkline Biologicals S.A. Method for identifying whether a patient will be responder or not to immunotherapy
WO2008063521A2 (en) * 2006-11-13 2008-05-29 The General Hospital Corporation Gene-based clinical scoring system
WO2008092002A2 (en) 2007-01-24 2008-07-31 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing pancreatic cancer
SI2132573T1 (sl) 2007-03-02 2014-07-31 Genentech, Inc. Napovedovanje odziva na inhibitor dimerizacije HER na osnovi nizke ekspresije HER3
US8592377B2 (en) 2007-03-28 2013-11-26 President And Fellows Of Harvard College Stitched polypeptides
WO2008150512A2 (en) * 2007-06-04 2008-12-11 University Of Louisville Research Foundation, Inc. Methods for identifying an increased likelihood of recurrence of breast cancer
PL2171090T3 (pl) * 2007-06-08 2013-09-30 Genentech Inc Markery ekspresji genów odporności guza na leczenie hamujące HER2
US9551033B2 (en) 2007-06-08 2017-01-24 Genentech, Inc. Gene expression markers of tumor resistance to HER2 inhibitor treatment
EP2228457A1 (en) * 2007-08-16 2010-09-15 Genomic Health, Inc. Gene expression markers of recurrence risk in cancer patients after chemotherapy
GB0720113D0 (en) * 2007-10-15 2007-11-28 Cambridge Cancer Diagnostics L Diagnostic, prognostic and predictive testing for cancer
WO2009067655A2 (en) * 2007-11-21 2009-05-28 University Of Florida Research Foundation, Inc. Methods of feature selection through local learning; breast and prostate cancer prognostic markers
EP2065475A1 (en) * 2007-11-30 2009-06-03 Siemens Healthcare Diagnostics GmbH Method for therapy prediction in tumors having irregularities in the expression of at least one VEGF ligand and/or at least one ErbB-receptor
WO2009114534A1 (en) * 2008-03-14 2009-09-17 The Regents Of The University Of California Multi-gene classifiers and prognostic indicators for cancers
BRPI0812682A2 (pt) 2008-06-16 2010-06-22 Genentech Inc tratamento de cáncer de mama metastático
US10359425B2 (en) * 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
US20100221752A2 (en) * 2008-10-06 2010-09-02 Somalogic, Inc. Ovarian Cancer Biomarkers and Uses Thereof
WO2010045234A1 (en) * 2008-10-14 2010-04-22 University Of Louisville Research Foundation, Inc. Methods of optimizing treatment of estrogen-receptor positive breast cancers
GB0821787D0 (en) * 2008-12-01 2009-01-07 Univ Ulster A genomic-based method of stratifying breast cancer patients
US20120041274A1 (en) 2010-01-07 2012-02-16 Myriad Genetics, Incorporated Cancer biomarkers
CA2764041A1 (en) * 2009-05-29 2011-01-13 Baylor College Of Medicine Dna repair or brca1-like gene signature
CN102421448A (zh) 2009-05-29 2012-04-18 霍夫曼-拉罗奇有限公司 Her2信号传导调控剂在表达her2的胃癌患者中
US20100316639A1 (en) 2009-06-16 2010-12-16 Genentech, Inc. Biomarkers for igf-1r inhibitor therapy
EP2275569A1 (en) * 2009-07-17 2011-01-19 Centre Leon Berard ZNF217 a new prognostic and predictive biomarker of recurrent, invasive and metastatic phenotypes in cancer
GB0917457D0 (en) * 2009-10-06 2009-11-18 Glaxosmithkline Biolog Sa Method
MX337650B (es) * 2009-11-23 2016-03-14 Genomic Health Inc Metodos para predecir el desenlace clinico del cancer.
US20130011393A1 (en) * 2010-01-12 2013-01-10 Johnathan Mark Lancaster Bad pathway gene signature
US20130143753A1 (en) * 2010-03-01 2013-06-06 Adelbio Methods for predicting outcome of breast cancer, and/or risk of relapse, response or survival of a patient suffering therefrom
WO2011146568A1 (en) 2010-05-19 2011-11-24 Genentech, Inc. Predicting response to a her inhibitor
EP3812469A1 (en) 2010-07-07 2021-04-28 Myriad Genetics, Inc. Gene signatures for cancer prognosis
SG186953A1 (en) 2010-07-09 2013-02-28 Somalogic Inc Lung cancer biomarkers and uses thereof
ES2711526T3 (es) 2010-08-13 2019-05-06 Aileron Therapeutics Inc Macrociclos peptidomiméticos
CN103415624B (zh) 2010-08-13 2017-03-01 私募蛋白质体公司 胰腺癌生物标记及其用途
US9605319B2 (en) 2010-08-30 2017-03-28 Myriad Genetics, Inc. Gene signatures for cancer diagnosis and prognosis
CA2818890C (en) 2010-11-23 2022-07-12 Krisani Biosciences (P) Ltd Method and system for prognosis and treatment of diseases using portfolio of genes
WO2012109233A2 (en) * 2011-02-07 2012-08-16 Board Of Regents, The University Of Texas System Methods for predicting recurrence risk in breast cancer patients
TW201806968A (zh) 2011-10-18 2018-03-01 艾利倫治療公司 擬肽巨環化合物
SG10202010758SA (en) * 2011-11-08 2020-11-27 Genomic Health Inc Method of predicting breast cancer prognosis
US9376715B2 (en) 2011-12-09 2016-06-28 Roche Molecular Systems, Inc Methods for detecting mutations in the catalytic subunit of the phosphoinositol-3 kinase (PIK3CA) gene
EP2819688A4 (en) 2012-02-15 2015-10-28 Aileron Therapeutics Inc TRIAZOL AND THIOETHER-COUPLED PEPTIDOMIMETIC MACROCYCLES
WO2013170174A1 (en) 2012-05-10 2013-11-14 H. Lee Moffitt Cancer Center And Research Institute, Inc. Method of diagnosing, treating and determining progression and survival of cancer cells using bcl-2 antagonist of cell death (bad) pathway gene signature
US9890430B2 (en) 2012-06-12 2018-02-13 Washington University Copy number aberration driven endocrine response gene signature
WO2014071241A1 (en) 2012-11-01 2014-05-08 Aileron Therapeutics, Inc. Disubstituted amino acids and methods of preparation and use thereof
CA2891653A1 (en) 2012-11-16 2014-05-22 Myriad Genetics, Inc. Gene signatures for cancer prognosis
KR102291355B1 (ko) 2012-11-30 2021-08-19 에프. 호프만-라 로슈 아게 Pd-l1 억제제 공동치료를 필요로 하는 환자의 식별방법
AU2014207429B2 (en) 2013-01-18 2018-11-01 Ellis KLINE Selective glycosidase regimen for immune programming and treatment of cancer
CN104981697B (zh) 2013-02-11 2017-08-04 英丘伦有限责任公司 促染色质转录复合物(fact)在癌症中的用途
CN103558383B (zh) * 2013-10-28 2015-11-18 深圳市第二人民医院 Aldh2基因在检测上尿路上皮癌中的应用
CN103558382B (zh) * 2013-10-28 2015-11-18 深圳市第二人民医院 Ccne1基因在检测上尿路上皮癌中的应用
KR20150088433A (ko) 2014-01-24 2015-08-03 삼성전자주식회사 c-Met 저해제의 효능 예측을 위한 바이오마커 TFF1
CA2947624A1 (en) 2014-05-13 2015-11-19 Myriad Genetics, Inc. Gene signatures for cancer prognosis
US10633710B2 (en) 2014-08-15 2020-04-28 Arizona Board Of Regents On Behalf Of The University Of Arizona Methods for characterizing cancer
EP3197478A4 (en) 2014-09-24 2018-05-30 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
AU2015320545C1 (en) 2014-09-24 2020-05-14 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and formulations thereof
BR112017007962A2 (pt) 2014-10-24 2018-01-23 Koninklijke Philips Nv método implementado por computador, aparelho, mídia de armazenamento, programa de computador, kit, e, uso do kit
CA2965217A1 (en) 2014-10-24 2016-04-28 Koninklijke Philips N.V. Medical prognosis and prediction of treatment response using multiple cellular signaling pathway activities
ES2833543T3 (es) 2014-10-24 2021-06-15 Koninklijke Philips Nv Evaluación de la actividad de la ruta de señalización celular de TGF usando modelos matemáticos de la expresión de genes diana
WO2016154058A1 (en) 2015-03-20 2016-09-29 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
EP3073268A1 (en) * 2015-03-27 2016-09-28 Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts Biomarker panel for diagnosing cancer
CA2995520A1 (en) 2015-08-14 2017-02-23 Hendrik Jan VAN OOIJEN Assessment of nfkb cellular signaling pathway activity using mathematical modelling of target gene expression
CN107058523A (zh) * 2017-03-21 2017-08-18 温州迪安医学检验所有限公司 一种乳腺癌复发风险评估21基因检测引物及其应用
EP3461915A1 (en) 2017-10-02 2019-04-03 Koninklijke Philips N.V. Assessment of jak-stat1/2 cellular signaling pathway activity using mathematical modelling of target gene expression
EP3461916A1 (en) 2017-10-02 2019-04-03 Koninklijke Philips N.V. Assessment of jak-stat3 cellular signaling pathway activity using mathematical modelling of target gene expression
EP3502279A1 (en) 2017-12-20 2019-06-26 Koninklijke Philips N.V. Assessment of mapk-ap 1 cellular signaling pathway activity using mathematical modelling of target gene expression
CN110045120A (zh) * 2018-01-15 2019-07-23 长庚医疗财团法人基隆长庚纪念医院 检测生物样品中wisp1的浓度在制备用于乳癌筛检及侦测复发的检测试剂盒及其应用
WO2020013355A1 (ko) * 2018-07-10 2020-01-16 서울대학교산학협력단 악성 엽상종 예후 예측용 조성물 및 이를 포함하는 키트
US20220326241A1 (en) * 2019-08-12 2022-10-13 Baylor College Of Medicine Proteogenomic methods for diagnosing cancer
CN113862363A (zh) * 2021-10-27 2021-12-31 中山大学附属第一医院 免疫相关基因在乳腺癌预后的试剂盒和系统中的应用
CN114480650A (zh) * 2022-02-08 2022-05-13 深圳市陆为生物技术有限公司 一种预测三阴乳腺癌临床预后复发风险的标志物及模型
WO2025076607A1 (pt) * 2023-10-09 2025-04-17 Liqsci Biotecnologia Ltda Processo in vitro para diagnóstico e/ou prognóstico de tumores em amostras líquidas, kit e processo in vitro para monitoramento do quadro clínico

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6378397B1 (en) * 2000-10-25 2002-04-30 Jenn Jianq Co., Ltd. Differential gearing device
US6655515B2 (en) * 2001-05-24 2003-12-02 Tecumseh Products Company Modular bi-directional overrunning wheel clutch

Family Cites Families (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE35491E (en) 1982-11-04 1997-04-08 The Regents Of The University Of California Methods and compositions for detecting human tumors
US4699877A (en) 1982-11-04 1987-10-13 The Regents Of The University Of California Methods and compositions for detecting human tumors
IE56509B1 (en) 1982-11-04 1991-08-28 Univ California Methods for oncogenic detection
US7838216B1 (en) 1986-03-05 2010-11-23 The United States Of America, As Represented By The Department Of Health And Human Services Human gene related to but distinct from EGF receptor gene
US5015568A (en) 1986-07-09 1991-05-14 The Wistar Institute Diagnostic methods for detecting lymphomas in humans
US5202429A (en) 1986-07-09 1993-04-13 The Wistar Institute DNA molecules having human BCL-2 gene sequences
US4968603A (en) 1986-12-31 1990-11-06 The Regents Of The University Of California Determination of status in neoplastic disease
US5831066A (en) 1988-12-22 1998-11-03 The Trustees Of The University Of Pennsylvania Regulation of bcl-2 gene expression
US5922855A (en) * 1993-12-17 1999-07-13 Oregon Health Sciences University Mammalian DNA mismatch repair genes MLH1 and PMS1
US6037134A (en) * 1994-03-07 2000-03-14 New York University Medical Center Methods that detect compounds that disrupt receptor tyrosine kinase/GRB-7 complexes
US7625697B2 (en) * 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby
US5858678A (en) 1994-08-02 1999-01-12 St. Louis University Apoptosis-regulating proteins
US5830753A (en) 1994-09-30 1998-11-03 Ludwig Institute For Cancer Research Isolated nucleic acid molecules coding for tumor rejection antigen precursor dage and uses thereof.
EP0951541B1 (en) 1995-07-31 2005-11-30 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate disease
US6218529B1 (en) * 1995-07-31 2001-04-17 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
US6716575B2 (en) 1995-12-18 2004-04-06 Sugen, Inc. Diagnosis and treatment of AUR1 and/or AUR2 related disorders
KR100459052B1 (ko) 1995-12-18 2005-01-15 서젠, 인크. Aur-1및(또는)aur-2관련질병의진단및치료
US5670325A (en) 1996-08-14 1997-09-23 Exact Laboratories, Inc. Method for the detection of clonal populations of transformed cells in a genomically heterogeneous cellular sample
US5741650A (en) 1996-01-30 1998-04-21 Exact Laboratories, Inc. Methods for detecting colon cancer from stool samples
US5821082A (en) 1996-05-23 1998-10-13 St. Louis University Health Sciences Center Anti-proliferation domain of a human Bcl-2 and DNA encoding the same
US5928870A (en) 1997-06-16 1999-07-27 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US6143529A (en) 1996-08-14 2000-11-07 Exact Laboratories, Inc. Methods for improving sensitivity and specificity of screening assays
US6100029A (en) 1996-08-14 2000-08-08 Exact Laboratories, Inc. Methods for the detection of chromosomal aberrations
US6020137A (en) 1996-08-14 2000-02-01 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US6203993B1 (en) 1996-08-14 2001-03-20 Exact Science Corp. Methods for the detection of nucleic acids
US5952178A (en) 1996-08-14 1999-09-14 Exact Laboratories Methods for disease diagnosis from stool samples
US6146828A (en) 1996-08-14 2000-11-14 Exact Laboratories, Inc. Methods for detecting differences in RNA expression levels and uses therefor
US5861278A (en) 1996-11-01 1999-01-19 Genetics Institute, Inc. HNF3δ compositions
ATE414149T1 (de) 1996-11-20 2008-11-15 Univ Yale Survivin, ein protein das zelluläre apoptosis hemmt, und dessen modulation
US5830665A (en) 1997-03-03 1998-11-03 Exact Laboratories, Inc. Contiguous genomic sequence scanning
US6033893A (en) 1997-06-26 2000-03-07 Incyte Pharmaceuticals, Inc. Human cathepsin
WO1999002714A1 (en) 1997-07-07 1999-01-21 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
EP1025220B1 (en) * 1997-10-21 2007-01-03 The University Court Of The University Of Glasgow JMY, A CO-ACTIVATOR FOR p300/CBP, NUCLEIC ACID ENCODING JMY AND USES THEREOF
JP2002505431A (ja) * 1998-02-25 2002-02-19 アメリカ合衆国 迅速な分子プロファイリングのための細胞アッセイ法
US6020135A (en) 1998-03-27 2000-02-01 Affymetrix, Inc. P53-regulated genes
WO1999064627A2 (en) 1998-06-06 1999-12-16 Genostic Pharma Limited Probes used for genetic profiling
WO1999064626A2 (en) 1998-06-06 1999-12-16 Genostic Pharma Limited Probes used for genetic profiling
US6696558B2 (en) 1998-09-09 2004-02-24 The Burnham Institute Bag proteins and nucleic acid molecules encoding them
AU2342900A (en) 1998-09-23 2000-05-01 Cleveland Clinic Foundation, The Novel interferon stimulated and repressed genes
US6251601B1 (en) 1999-02-02 2001-06-26 Vysis, Inc. Simultaneous measurement of gene expression and genomic abnormalities using nucleic acid microarrays
US9534254B1 (en) 1999-02-02 2017-01-03 Abbott Molecular Inc. Patient stratification for cancer therapy based on genomic DNA microarray analysis
WO2000050595A2 (en) 1999-02-25 2000-08-31 Ivan Gout Nucleic acid molecules associated with melanoma and thyroid tumors
US20020039764A1 (en) 1999-03-12 2002-04-04 Rosen Craig A. Nucleic, acids, proteins, and antibodies
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
US6960439B2 (en) 1999-06-28 2005-11-01 Source Precision Medicine, Inc. Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
US6692916B2 (en) 1999-06-28 2004-02-17 Source Precision Medicine, Inc. Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
US6326148B1 (en) 1999-07-12 2001-12-04 The Regents Of The University Of California Detection of copy number changes in colon cancer
US6710170B2 (en) 1999-09-10 2004-03-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
US6271002B1 (en) 1999-10-04 2001-08-07 Rosetta Inpharmatics, Inc. RNA amplification method
WO2001025250A1 (en) 1999-10-06 2001-04-12 The Regents Of The University Of California Differentially expressed genes associated with her-2/neu overexpression
CA2491433A1 (en) 1999-12-01 2001-06-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6750013B2 (en) 1999-12-02 2004-06-15 Protein Design Labs, Inc. Methods for detection and diagnosing of breast cancer
US6248535B1 (en) 1999-12-20 2001-06-19 University Of Southern California Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens
WO2001051664A2 (en) * 2000-01-12 2001-07-19 Dana-Farber Cancer Institute, Inc. Method of detecting and characterizing a neoplasm
EP1276901A2 (en) 2000-01-13 2003-01-22 Amsterdam Support Diagnostics B.V. A universal nucleic acid amplification system for nucleic acids in a sample
US6322986B1 (en) 2000-01-18 2001-11-27 Albany Medical College Method for colorectal cancer prognosis and treatment selection
CA2398107C (en) 2000-01-28 2013-11-19 Althea Technologies, Inc. Methods for analysis of gene expression
WO2001055301A2 (en) 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
WO2001070979A2 (en) 2000-03-21 2001-09-27 Millennium Pharmaceuticals, Inc. Genes, compositions, kits, and method for identification, assessment, prevention and therapy of ovarian cancer
US7157227B2 (en) 2000-03-31 2007-01-02 University Of Louisville Research Foundation Microarrays to screen regulatory genes
WO2002000677A1 (en) 2000-06-07 2002-01-03 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
MXPA03000575A (es) 2000-07-21 2004-12-13 Global Genomics Ab Metodos para analisis e identificacion de genes transcritos e impresion dactilar.
AU2001277202A1 (en) 2000-07-26 2002-02-05 Applied Genomics, Inc. Bstp-ras/rerg protein and related reagents and methods of use thereof
WO2002008765A2 (en) 2000-07-26 2002-01-31 Stanford University Basal cell markers in breast cancer and uses thereof
AU2001278011A1 (en) 2000-07-26 2002-02-05 Applied Genomics, Inc. Bstp-ecg1 protein and related reagents and methods of use thereof
WO2002010436A2 (en) * 2000-07-28 2002-02-07 The Brigham And Women's Hospital, Inc. Prognostic classification of breast cancer
US7795232B1 (en) 2000-08-25 2010-09-14 Genta Incorporated Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
US6582919B2 (en) 2001-06-11 2003-06-24 Response Genetics, Inc. Method of determining epidermal growth factor receptor and HER2-neu gene expression and correlation of levels thereof with survival rates
US6602670B2 (en) 2000-12-01 2003-08-05 Response Genetics, Inc. Method of determining a chemotherapeutic regimen based on ERCC1 expression
US20030143539A1 (en) * 2000-12-08 2003-07-31 Francois Bertucci Gene expression profiling of primary breast carcinomas using arrays of candidate genes
AU2002255478A1 (en) 2001-01-10 2002-09-12 Pe Corporation (Ny) Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
US7776518B2 (en) 2001-01-12 2010-08-17 Yale University Detection of survivin in the biological fluids of cancer patients
JP4368110B2 (ja) 2001-01-12 2009-11-18 エール ユニヴァーシティ 癌患者の生物学的流体中のサバイビンの検出
JP2005503760A (ja) 2001-01-24 2005-02-10 プロテイン デザイン ラブス， インコーポレイテッド 乳癌の診断方法、組成物および乳癌のモジュレーターのスクリーニング方法
WO2002059271A2 (en) * 2001-01-25 2002-08-01 Gene Logic, Inc. Gene expression profiles in breast tissue
KR20030094281A (ko) 2001-03-12 2003-12-11 모노젠, 인크. 세포에 기초한 질병상태의 검출 및 질병상태의 구별
US20050260572A1 (en) * 2001-03-14 2005-11-24 Kikuya Kato Method of predicting cancer
EP1410011B1 (en) 2001-06-18 2011-03-23 Rosetta Inpharmatics LLC Diagnosis and prognosis of breast cancer patients
US7125680B2 (en) 2001-07-27 2006-10-24 The Regents Of The University Of California Methods and materials for characterizing and modulating interaction between heregulin and HER3
US6898531B2 (en) * 2001-09-05 2005-05-24 Perlegen Sciences, Inc. Algorithms for selection of primer pairs
US20040009489A1 (en) 2001-09-28 2004-01-15 Golub Todd R. Classification of lung carcinomas using gene expression analysis
US6964850B2 (en) 2001-11-09 2005-11-15 Source Precision Medicine, Inc. Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
US20030198972A1 (en) 2001-12-21 2003-10-23 Erlander Mark G. Grading of breast cancer
ES2374311T3 (es) * 2002-03-13 2012-02-15 Genomic Health, Inc. Obtención de perfil de expresión génica en tejidos tumorales biopsiados.
EP1492871A2 (en) 2002-03-28 2005-01-05 QLT Inc. Cancer associated protein kinases and their uses
EP1365034A3 (en) 2002-05-21 2004-02-18 Bayer HealthCare AG Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of malignant neoplasia
AU2003295600A1 (en) * 2002-11-14 2004-06-15 Dharmacon, Inc. Functional and hyperfunctional sirna
DE602004015064D1 (de) * 2003-01-06 2008-08-28 Wyeth Corp Zusammensetzungen und verfahren zur diagnose und behandlung von kolonkrebs
US20040231909A1 (en) * 2003-01-15 2004-11-25 Tai-Yang Luh Motorized vehicle having forward and backward differential structure
WO2004074518A1 (en) 2003-02-20 2004-09-02 Genomic Health, Inc. Use of intronic rna to measure gene expression
AU2004248120B2 (en) 2003-05-28 2009-04-23 Genomic Health, Inc. Gene expression markers for predicting response to chemotherapy
HUE050365T2 (hu) * 2003-06-24 2022-09-28 Genomic Health Inc Rákkiújulás valószínûségének elõrejelzése
AU2004258085B2 (en) 2003-07-10 2010-05-27 Genomic Health, Inc. Expression profile algorithm and test for cancer prognosis
ES2636470T3 (es) 2004-04-09 2017-10-05 Genomic Health, Inc. Marcadores de expresión génica para predecir la respuesta a la quimioterapia
CA2585571C (en) 2004-11-05 2020-01-21 Genomic Health, Inc. Predicting response to chemotherapy using gene expression markers
JP4939425B2 (ja) 2004-11-05 2012-05-23 ジェノミック ヘルス， インコーポレイテッド 乳癌の治療反応の予後および予測の分子指標
WO2007028146A2 (en) 2005-09-01 2007-03-08 Precision Therapeutics, Inc. Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics
EP1777523A1 (en) 2005-10-19 2007-04-25 INSERM (Institut National de la Santé et de la Recherche Médicale) An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
US7888019B2 (en) 2006-03-31 2011-02-15 Genomic Health, Inc. Genes involved estrogen metabolism
EP2228457A1 (en) 2007-08-16 2010-09-15 Genomic Health, Inc. Gene expression markers of recurrence risk in cancer patients after chemotherapy
EP2294215B1 (en) 2008-05-12 2013-01-16 Genomic Health, Inc. Tests to predict responsiveness of cancer patients to chemotherapy treatment options
KR101759175B1 (ko) 2009-07-02 2017-07-18 바스프 에스이 공-응집된 라텍스 중합체 분산액 및 그의 제조 및 사용 방법
MX337650B (es) 2009-11-23 2016-03-14 Genomic Health Inc Metodos para predecir el desenlace clinico del cancer.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6378397B1 (en) * 2000-10-25 2002-04-30 Jenn Jianq Co., Ltd. Differential gearing device
US6655515B2 (en) * 2001-05-24 2003-12-02 Tecumseh Products Company Modular bi-directional overrunning wheel clutch

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103465779A (zh) * 2013-09-17 2013-12-25 哈尔滨工程大学 双引擎全向四驱行进机构

Also Published As

Publication number Publication date
JP4723472B2 (ja) 2011-07-13
WO2004065583A3 (en) 2005-03-03
HK1148783A1 (en) 2011-09-16
DK2230319T3 (en) 2016-01-25
ES2346967T3 (es) 2010-10-22
EP2230319B1 (en) 2015-10-21
EP2230319A2 (en) 2010-09-22
AU2004205878A1 (en) 2004-08-05
US8741605B2 (en) 2014-06-03
ATE470723T1 (de) 2010-06-15
CA2829477A1 (en) 2004-08-05
CA2829476C (en) 2018-07-10
US20040209290A1 (en) 2004-10-21
EP3059322A1 (en) 2016-08-24
EP2230318A1 (en) 2010-09-22
US20110312532A1 (en) 2011-12-22
CA2513117C (en) 2014-02-25
US20100222229A1 (en) 2010-09-02
EP3059322B1 (en) 2019-04-10
EP1587957B1 (en) 2010-06-09
JP2006516897A (ja) 2006-07-13
DK3059322T3 (da) 2019-05-06
CA2829472A1 (en) 2004-08-05
CA2829477C (en) 2018-07-10
WO2004065583A2 (en) 2004-08-05
AU2009238287A1 (en) 2009-12-03
AU2009238287B2 (en) 2012-06-28
US7569345B2 (en) 2009-08-04
AU2004205878A8 (en) 2004-08-05
US8206919B2 (en) 2012-06-26
EP2230319A3 (en) 2011-01-12
DE602004027600D1 (de) 2010-07-22
CA2829476A1 (en) 2004-08-05
CA3013889A1 (en) 2004-08-05
US20180230548A1 (en) 2018-08-16
US9944990B2 (en) 2018-04-17
ES2561179T3 (es) 2016-02-24
CA2829472C (en) 2018-08-14
US11220715B2 (en) 2022-01-11
ES2725892T3 (es) 2019-09-30
AU2004205878B2 (en) 2009-08-27
US8034565B2 (en) 2011-10-11
CA2513117A1 (en) 2004-08-05
DK1587957T3 (da) 2010-09-27
US20120225433A1 (en) 2012-09-06
EP1587957A2 (en) 2005-10-26
US20140287421A1 (en) 2014-09-25

Similar Documents

Publication Publication Date Title
US20040231909A1 (en) Motorized vehicle having forward and backward differential structure
EP0962349B1 (en) Power transmission device
EP2365917B1 (en) Final drive for a work machine
US20110120794A1 (en) Chain Gear, Vehicle Comprising a Chain Gear and Method for Transforming a motor Torque in a Vehicle
JP5026434B2 (ja) 減速機
US6080077A (en) Planetary gear drive train
US4729257A (en) Balanced steerable transmission
JPH10278813A (ja) 電動パワーステアリング装置
US20020130483A1 (en) Chainless transmission mechanism for bicycles
SE504653C2 (sv) Kompaktkuggväxel med stort utväxlingsförhållande
CN101254745A (zh) 行星锥盘式自动变速电动轮毂
US20150246710A1 (en) Power module of electric bicycle
KR200336799Y1 (ko) 단일 차동수단을 갖는 변속장치
ATE315485T1 (de) Zwillingsräder mit differential
US6689009B1 (en) Compact differential assembly
US6776737B2 (en) Planetary differential gear
JP4072234B2 (ja) クラッチ装置
EP1467125A2 (en) Planetary differential gear
CN114929570A (zh) 带侧装车轮的前电机驱动自行车
US5088969A (en) Bifurcated transmission drive
CN220320221U (zh) 一种等中心距传动结构
JP2008281159A (ja) デファレンシャル装置
US6561594B1 (en) Wheel shaft structure of monocycle
US20060270511A1 (en) Differential gear apparatus
US6378397B1 (en) Differential gearing device

Legal Events

Date Code Title Description
AS Assignment

Owner name: TAIWAN POWER INDUSTRIAL CO., LTD., TAIWAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:LUH, TAI-YANG;REEL/FRAME:014095/0612

Effective date: 20030505

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION